Bellus Health Shares Outstanding 2006-2021 | BLU

Bellus Health shares outstanding from 2006 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Bellus Health Annual Shares Outstanding
(Millions of Shares)
2020 59
2019 47
2018 34
2017 19
2016 16
2015 13
2014 13
2013 12
2012 9
2011 3
2010 2
2009 1
2008 0
2007 0
2006 0
2005 0
Bellus Health Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 78
2021-03-31 78
2020-12-31 59
2020-09-30 60
2020-06-30 60
2020-03-31 56
2019-12-31 47
2019-09-30 47
2019-06-30 44
2019-03-31 44
2018-12-31 34
2018-09-30 33
2018-06-30 43
2018-03-31 33
2017-12-31 19
2017-09-30 19
2017-06-30 19
2017-03-31 18
2016-12-31 16
2016-09-30 17
2016-06-30 16
2016-03-31 15
2015-12-31 12
2015-09-30 13
2015-06-30 12
2015-03-31 13
2014-12-31 13
2014-09-30 20
2014-06-30 10
2014-03-31 19
2013-12-31 14
2013-09-30 15
2013-06-30 12
2013-03-31 13
2012-12-31 9
2012-09-30 7
2012-06-30 7
2012-03-31 3
2011-12-31 2
2011-09-30 3
2011-06-30 2
2011-03-31 3
2010-12-31 2
2010-09-30 2
2010-06-30 2
2010-03-31 2
2009-12-31 2
2009-09-30 1
2009-06-30 1
2009-03-31 0
2008-12-31 0
2008-09-30 0
2008-06-30 0
2008-03-31 0
2007-12-31 0
2007-09-30 0
2007-06-30 0
2007-03-31 0
2006-12-31 0
2006-09-30 0
2005-12-31 0
2005-09-30 0
2005-06-30 0
2005-03-31 0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.499B $0.000B
BELLUS Health is a global health company focused on the development and commercialization of products to provide innovative health solutions to address critical unmet medical needs.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.838B 8.91
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.341B 20.90
Biohaven Pharmaceutical Holding (BHVN) United States $8.723B 0.00
Emergent Biosolutions (EBS) United States $2.813B 6.79
Arcus Biosciences (RCUS) United States $2.568B 0.00
Myovant Sciences (MYOV) United Kingdom $2.170B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.949B 0.00
Zymeworks (ZYME) Canada $1.323B 0.00
Ambrx Biopharma (AMAM) United States $0.509B 0.00
SQZ Biotechnologies (SQZ) United States $0.428B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29